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Radioprotection by 2,3-dimethyl-6-(2-(dimethylamino)ethyl)-6H-indolo[2,3-b]quinoxaline (B220) on survival and growth of female C3H 
mice exposed to acute whole-body gamma-radiation was evaluated for 7.5-8 months following irradiation in two separate experiments. For 
adult (12 weeks old) mice, B220 administration increased median survival after 8 Gy by a factor of 1.27 when given within 24 h pre-
irradiation, administration up to 24 h post-irradiation had a similar effect (1.20) but in addition resulted in 1 of 9 (11 %) mice alive after 32 
weeks. For adult mice irradiated with 10-14 Gy, B220 had no significant effect on survival. For very young mice (4 weeks old), however, 
B220 administration within 24 h pre-irradiation protected from growth retardation at both 1 and 6 Gy, and from gray-hairing at 6 Gy. In 
conclusion, the well tolerated drug B220 offered radioprotection in both studies and its administration could be further optimized. 
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INTRODUCTION 
Ionising gamma ()-irradiation causes radiation damage in 
biological organisms. Reactive species are produced through 
radiolysis of water (e.g. HO•, H•, eaq-) and ionization of 
biomolecules such as proteins, DNA and lipids make them 
prone to reactions with molecular oxygen (O2).1,2 The 
damage (disintegration and oxidation of organic molecules) 
initiates an inflammatory response with attacking 
neutrophils (granulocytes, monocytes and macrophages) 
releasing various reactive oxygen species (ROS).1,2 
Drugs initially found to protect from -irradiation, such as 
sulfhydryls3 and WR-2721 (amifostine)4 give side effects at 
high doses or offer limited protection in certain organs (e.g. 
the central nervous system).1,5 More recently, however, 
some interesting examples have been reported including 
flavonoids,6 caffeine,7 α-TMG (vitamin E analog),8 Mentha 
arvensis (mint),9 5-androstenediol,10 Tempol,11 molecular 
hydrogen (H2) containing water,5 Ex-Rad™,12 JNJ7777120 
(indole),13 and particularly the recently studied indole 3,3'-
diindolylmethane (DIM; derived from ingestion of indole-3-
carbinol found in cruciferous vegetables such as cabbage, 
Brussels sprouts and broccoli) that offered astonishing 
radioprotection also at very high doses (up to 13 Gy) both in 
vivo and in cell culture.14 
The synthetic indole-drug 2,3-dimethyl-6-((2-
(dimethylamino)ethyl)-6H-indolo[2,3-b]quinoxaline (B220, 
structure shown in figure 1) has been found to be well 
tolerated, having preventative effects on growth of 12-O-
tetradecanoylphorbol-13-acetate (TPA) promoted skin 
tumours in vivo possibly by interfering with enzymes 
involved in the generation of ROS in the inflammatory 
response to TPA,15 and was found to downregulate 
phagocyte NADPH-oxidase activity in vitro, inhibiting 
release of ROS, by affecting signalling downstream of 
protein kinase C (PKC).16 
 
 
 
 
 
 
Figure 1. 2,3-Dimethyl-6-((2-dimethylamino)ethyl)-6H-indolo-
[2,3-b]quinoxaline (B220). 
Based on these protective roles of B220 on reducing ROS 
production, the aim of this study was to test if B220 would 
have any protective effect on -irradiation in vivo. Mortality, 
weight gain (growth) and other possible complications was 
investigated after whole-body -irradiation of C3H female 
mice given B220 intraperitoneally (i.p.) at a dose similar to 
those used in some previous radioprotector studies.7,9 
RESULTS 
Study I: adult (12 weeks old) mice exposed to 0-14 Gy 
As shown in Table 1 and Figure 2, at high doses -
radiation (10, 12, 14 Gy) all the 12 weeks old mice had died 
after 13 days and no effect of B220 was seen. A sharp 
threshold for survival was noticed between 6 and 8 Gy: 
nearly all mice exposed to 6 Gy survived (one animal in the 
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6 Gy control group died 31 weeks after irradiation) during 
the investigated period over 32 weeks (7.5 months) 
following irradiation, but most mice exposed to 8 Gy died 
within 25 days. At 8 Gy, pre-administration of B220 
increased the median survival time by 27 % (from 15 to 19 
days). B220 given post-irradiation increased the median 
survival time by 20 % (from 15 to 18 days) and in addition 
resulted in 11.1 % long-term survival as one mouse was still 
alive at the end of study (this mouse became gray-haired 10 
weeks after irradiation, at age 23 weeks). 
 
 
 
 
 
 
Figure 2. Survival curves as  % alive for adult (12 weeks old) 
female C3H mice exposed to 0-14 Gy whole-body γ-radiation.  
 
The Gehan-Breslow-Wilcoxon survival curve analysis test 
showed that administration of B220 post-irradiation 
significantly increased the survival compared to no B220 
administration at 8 Gy (p=0.04). The 6 Gy mice developed 
gray-haired skin 11 weeks after irradiation, at age 24 weeks.  
 
Table 1. Lethality and effect of B220 upon whole-body -
irradiation of adult (12 weeks old) female C3H mice followed for 
32 weeks. 
 Median survival in days Effect of B220 
Gy Control +B220 
pre-ir. 
+B220 
post-ir. 
 
14 7 (N=8) 6 (N=9) - none 
12 9 (N=8) 9 (N=9) - none 
10 11(N=8) 11(N=9) - none 
8 15 (N=8) 19 (N=8) 18 
(N=9) 
pre-ir: 27 % 
increase 
post-ir.: 20 % 
increase and 
11 % long time 
survival 
6 one death 
after 31 
weeks 
(N=8) 
no death 
(N=9) 
- none 
4 no death 
(N=8) 
no death 
(N=9) 
- none 
2 no death 
(N=8) 
no death 
(N=9) 
- none 
0 no death 
(N=8) 
no death 
(N=8) 
- none 
Mice in the 4, 2 and 0 Gy groups all survived and had not 
become gray-haired at end of the study. Mean body weights 
for the 17 groups at the beginning of the study (12 weeks 
old) lay in the range 23.3-26.5 g. At the end of study, mean 
body weights in surviving groups (6, 4, 2 and 0 Gy) lay in 
the range 34.7-41.8 g and no significant effect due to 
irradiation could be seen among groups not administrated 
B220. Also, B220 had no effect on weight gain in these 
groups. 
Study II: 4 weeks old mice exposed to 0, 1 and 6 Gy 
As shown in figure 3, both 1 and 6 Gy retarded growth for 
the very young mice compared to non-irradiated mice. On 
the day of irradiation, the six groups' mean weights were 
12.6-14.6 g. After rapidly gaining weight, average weights 
were 29.0-38.9 g at week 36 (8 months after irradiation, at 9 
months of age), reflecting a 209-285 weight  % increase 
versus the day of irradiation depending on group (Figure 
3A). The weight  % data for both individual mice and as 
group means could be well fitted to two-phase association 
curves (Figure 3A). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Effect of whole body γ-irradiation (0, 1 and 6 Gy) and 
B220 pre-administration on growth of 4-week-old female mice. 
Data shown as averages in A and means ± SEM in B. 
Calculation of area under curve (AUC) values for the 
individual mice (N=5 per group) allowed statistical 
comparisons among groups. Analysis using two-way 
ANOVA (Figure 3B) determined that growth was overall 
retarded due to radiation (p < 0.001), that B220 exerted a 
protective effect (p < 0.05) and that there was an interaction 
between radiation and B220 (p < 0.01), thus that B220 
counteracted growth retardation due to irradiation. The 
Bonferroni post test (*) identified protection by B220 at 
both 1 (p < 0.05) and 6 Gy (p < 0.05). At 0 Gy, however, 
B220 administration had no effect on weight gain. One-way 
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ANOVA analysis of groups not administered B220 showed 
that growth was retarded at 1 Gy (p < 0.05 (†)) and that 6 
Gy affected growth even more (p < 0.05 (#)). At 6 Gy, the 
mice developed gray-haired skin about 18 weeks after 
irradiation (at age 22 weeks) and B220 reduced the degree 
of gray-hairing (visual observation). One mouse in each of 
the 6 Gy groups died 25 weeks after irradiation (for AUC 
calculations their weights were assumed constant until the 
end of study). 
Toxicity of B220 
No signs of clinical toxicity were seen after two i.p. 
administrations of B220 at 25 mg kg-1 body weight doses (in 
total 50 mg kg-1 body weight) with a gap of 22 h in between. 
Topical administration of 1 mg B220 alone twice a week 
for 20 weeks had previously not shown any apparent 
toxicity.15 
DISCUSSION 
This study provides detailed information regarding 
mortality and growth of female C3H mice after acute -
irradiation. For adult mice (Study I), B220 showed 
protective effects at 8 Gy (Figure 2) when administrated 24 
and 2 h before, or, 2 and 24 h after, irradiation. For 4 weeks 
old mice (Study II), B220 counteracted growth retardation at 
1 and 6 Gy (Fig 3) and decreased gray hairing of skin at 6 
Gy. For 4 weeks old mice, 1 Gy caused adverse 
developmental effects on growth, whereas further weight 
gain in adult mice was not affected by as much as 6 Gy. At 6 
Gy, both the 12 and 4 week old mice became gray-haired at 
about the same age (at 24 and 22 weeks of age, respectively), 
thus the adult mice became gray-haired considerably sooner 
after irradiation.  
Regarding drug administration pre- or post-irradiation for 
optimal protection from -radiation damage, studies by 
others have found that both ways can work. Dosing with 
DIM either before or up to 24 h after irradiation protected 
rats from lethal irradiation doses up to as high as 13 Gy.14 
The time-point of drug administration may indeed play a 
role. In a study on 7-8 week old C57BL/6 mice exposed to 8 
Gy whole-body γ-irradiation, switching to a diet high in 
antioxidant supplements 24 h after the irradiation event 
significantly increased the survival and was considerably 
more efficient than when beginning the antioxidant 
administration 12 or 48 h after irradiation.17 The reason for 
this is unclear. Also the dose and frequency of 
administration can play a role. For the two flavonoids 
orientin and vicenin, both worked better as radioprotectors 
at 50 than at 75 or 100 μg kg-1 body weight.6 Maximum 
protection was achieved by administration 30 min before 
irradiation, injection at other time points (2 or 1 h before, or 
30 min after) offered less protection.6 DIM, however, 
offered better protection at 75 mg kg-1 body weight than at 
lower doses when administered on 14 consecutive days after 
irradiation to 13 Gy.14 
Mechanistically, the various radioprotectors have been 
suggested to act very differently. Dephosphorylation of WR-
2721 produces the active cell-permeant thiol metabolite 
WR-1065, which has been reported to suppress the 
reactivity of intralysosomal iron.18 Flavonoids, α-TMG, H2, 
and Tempol presumably react with or modify free radicals 
and ROS.5,6,8,11 Ex-Rad™ was reported to manifest its 
protective effects through up-regulation of PI3-Kinase/AKT 
pathways in cells exposed to radiation.19 A suggested 
protective mechanism for DIM proceeds through activation 
of the nuclear kinase at axiateleangiectasia mutated (ATM) 
regulating responses to DNA damage and oxidative stress, 
and NF-κB activation.14 The indole JNJ7777120 acts as a 
potent and selective antagonist of the histamine H4 
receptor,13 a member of the G protein-coupled receptor 
super family. The mechanism for the observed protection of 
B220 is unclear but is possibly due to its observed ability to 
down-regulate the secondary release of ROS by 
neutrophils,16 preventing further oxidative stress after 
irradiation, and is not  likely due to OH•-scavenging as B220 
has been reported to poorly scavenge OH•.16 B220 is also a 
DNA intercalator.20 
In conclusion, B220 was found to be well tolerated at the 
dose tested and somewhat radioprotective in whole-body -
irradiated mice. As no toxicity from B220 was observed this 
raises the chance for optimisation of B220 administration in 
terms of quantity and number of doses over time, something 
that likely will enhance the protective effects of B220 
further. 
MATERIALS AND METHODS 
Animals and experimental design 
Dark female C3H mice were ordered from M&B A/S 
(Denmark) and were allowed to acclimatize at the animal 
facility for a minimum of 5 days. Two separate whole body 
-irradiation studies were performed: (I) evaluation of 
B220's effect on survival of adult (12 weeks old) mice 
exposed to 0–14 Gy (0, 2, 4, 6, 8, 10, 12, 14 Gy; n = 8–9 
mice per group) ± pre-administration of B220 at all 
irradiation doses (for 8 Gy, a separate group given B220 
post-irradiation was also included), and, (II) evaluation of 
B220's effect on growth of very young mice (4 weeks old) 
irradiated with 0, 1 and 6 Gy (n = 5 mice per group). 
Animals were randomly allocated to groups. In both studies, 
surviving mice were carefully examined (physical 
appearance, body weight, etc.) weekly for at least 7.5 
months after irradiation when they were humanely 
euthanized. The groups were kept in separate cages at the 
animal facility at Huddinge Hospital under controlled 
conditions with food and water available before and after 
irradiation. Cage size was adjusted to group size. The ethical 
permit for the study was S141/96, approved by Stockholm 
South Ethical Committee on Animal Research, and all 
experiments were performed in accordance with relevant 
guidelines and regulations. 
Preparation of B220 
B220 base was synthesised according to an earlier 
published method.21 B220 was dissolved in acetone, then 
fresh corn oil was added and the solution stirred until all 
acetone had evaporated giving a final concentration of 1.7-
3.2 mg B220 mL-1, depending on the study. The solutions 
were stored protected from light at room temperature. 
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Administration of B220 
After recording body weights, B220 was administrated. 
Animals received two 200 µl doses (i.p.)   of corn oil 
containing B220 at a concentration giving 25 mg kg-1 of 
body weight each (in total 50 mg kg-1 of body weight), 
administered either before or after irradiation. Controls 
received corn oil. For pre-administration, the first dose was 
given 24 h before and the other dose 2 h before irradiation. 
For post-administration, one dose was given 2 h and the 
other 24 h after irradiation. 
Irradiation of mice 
On the day of -irradiation the mice were transported to 
the Department of Radiation Biology, Stockholm University. 
Irradiation was carried out using 137Cs at 0.65 Gy min-1 
inside a routinely dosimetry checked apparatus from 
Instrument AB Scanditronix (Uppsala, Sweden). Animals 
were whole-body exposed in round well-ventilated 
compartmentalised plastic boxes (taking up to 10 mice 
simultaneously). 
Observation 
The mice were carefully monitored daily the first month 
after -irradiation and then once a week for at least 32 weeks 
(7.5 months), checking signs of clinical toxicity (survival, 
weight, physical appearance, etc.). Survival curves were 
plotted using the Kaplan-Meier method. 
Statistical analyses 
Statistical significance was set to p<0.05 and analyses 
conducted using GraphPad Prism 5 (San Diego, California). 
Survival curves were compared using Log-rank (Mantel-
Cox) and Gehan-Breslow-Wilcoxon tests. After normalizing 
body weights to the time-point of irradiation (set to 100 %), 
the areas under the growth curves were integrated (gives 
AUC values) for statistical comparison using one- and two-
way ANOVA analyses. 
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